FDA Drug Application (205223) for NUVESSA by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number205223
Product Number001
FormGEL;VAGINAL
Dosage1.3%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNUVESSA
Active IngredientMETRONIDAZOLE

Active IngredientCount
List of drugs with Active Ingredient METRONIDAZOLE19


Back to FDA Applications sponsored by ALLERGAN SALES LLC